Development and validation of a low cost blood filtration element separating plasma from undiluted whole blood.

Development and validation of a low cost blood filtration element separating plasma from undiluted whole blood.

Item
http://www.wikidata.org/entity/Q42182588
A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulantsA pillar-based microfilter for isolation of white blood cells on elastomeric substrate.Preface to special topic: selected papers from the second conference on advances in microfluidics and nanofluidics and Asia-pacific international symposium on lab on chip.Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.Cocaine detection by a mid-infrared waveguide integrated with a microfluidic chip.Limited utility of dried-blood- and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0.A high-efficiency superhydrophobic plasma separator.Field tested milliliter-scale blood filtration device for point-of-care applications.Membrane-based, sedimentation-assisted plasma separator for point-of-care applicationsCharacterization of thermoplastic microfiltration chip for the separation of blood plasma from human blood.Printed microfluidic filter for heparinized blood.Development of a microfluidic device for cell concentration and blood cell-plasma separation.Potential Point-of-Care Microfluidic Devices to Diagnose Iron Deficiency Anemia
P2860

Development and validation of a low cost blood filtration element separating plasma from undiluted whole blood.

Item
http://www.wikidata.org/entity/Q42182588
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Development and validation of ...... ma from undiluted whole blood.
@en
Development and validation of ...... ma from undiluted whole blood.
@nl
type
label
Development and validation of ...... ma from undiluted whole blood.
@en
Development and validation of ...... ma from undiluted whole blood.
@nl
prefLabel
Development and validation of ...... ma from undiluted whole blood.
@en
Development and validation of ...... ma from undiluted whole blood.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Development and validation of ...... ma from undiluted whole blood.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932